Evidence map›Paper›PMID 32761193›Full record

Observational studyThe Journal of infectious diseases2021

An Inflammatory Composite Score Predicts Mycobacterial Immune Reconstitution Inflammatory Syndrome in People with Advanced HIV: A Prospective International Cohort Study.

Caian L Vinhaes, Virginia Sheikh, Deivide Oliveira-de-Souza, Jing Wang, Adam Rupert, Gregg Roby, María B Arriaga, Kiyoshi F Fukutani, Fred Sawe, Doug Shaffer and 4 more

Registry-linked trialOpen access · greenAbstract readObservational Study
In one paragraph

Observational study in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00286767 (A Cohort Observational Study Evaluating Predictors, Incidence and Immunopathogenesis of Immune Reconstitution Syndrome), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00286767 completednot on this map

A Cohort Observational Study Evaluating Predictors, Incidence and Immunopathogenesis of Immune Reconstitution Syndrome (IRIS) in HIV-1 Infected Patients With CD4 Count Less Than or Equal to 100 Cells/microL Who Are Initiating Antiretroviral Therapy

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2006 to 2018Enrolled525ConditionsImmune Reconstitution Inflammatory Syndrome
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Compartment-specific inflammation in tuberculous lymphadenitis: a case-control study.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  5. [Characterization of immune reconstitution inflammatory syndrome in a Mexican cohort].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 5 countries.

Caian L VinhaesInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Virginia SheikhNational Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Deivide Oliveira-de-SouzaInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Jing WangNational Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Adam RupertNational Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Gregg RobyNational Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
María B ArriagaInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Kiyoshi F FukutaniInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Fred SaweKenya Medical Research Institute, Henry Jackson Foundation Medical Research International, Bethesda, Maryland, USA.
Doug ShafferKenya Medical Research Institute, Henry Jackson Foundation Medical Research International, Bethesda, Maryland, USA.
Jintanat AnanworanichSouth East Asia Research Collaboration with Hawaii, Henry M. Jackson Foundation for the Advancement of Military Medicine, United States Military HIV Research Program, Bethesda, Maryland, USA.
Nittaya PhanuphakThai Red Cross AIDS Research Centre, Bangkok, Thailand.
Bruno B AndradeInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Irini SeretiNational Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
National Institutes of Health · USFaculdade de Tecnologia e Ciências · BRKenya Medical Research Institute · KEUniversidade Federal da Bahia · BRFundação Oswaldo Cruz · BRHenry M. Jackson Foundation · USThai Red Cross Society · TH

Funding

CCASAnet: Caribbean, Central and South America NetworkU01AI069923 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Pedro Enrique Cahn, Jessica L Castilho · 2006 to 2026
$41.6M
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) DiseaseZIAAI001121 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SERETI, IRINI · 2010 to 2025
$27.2M
Inflammatory determinants of disease severity and treatment outcome in TB patientsU01AI115940 · NIAID · UNIVERSITY OF CAPE TOWN · PI SHER, ALAN, WILKINSON, ROBERT JOHN · 2015 to 2019
$1.1M
NIAID NIH HHS U01 AI069923NIAID NIH HHS U01 AI115940
6 · The paper itself

Abstract

backgroundImmune reconstitution inflammatory syndrome (IRIS) is a common cause of morbidity among people with human immunodeficiency virus (PWH) who initiate antiretroviral therapy (ART) with severe lymphopenia. Easily accessible tools that reliably predict emergence and elucidate pathogenesis of IRIS are needed to facilitate improved clinical management.

methodsPlasma levels of biomarkers were measured before ART initiation in a large multinational cohort of ART-naive PWH with severe immunosuppression (CD4+ count <100 cells/mm3) in United States, Kenya, and Thailand. We performed a series of multiparametric analyses of inflammatory and clinical biomarkers and developed a composite score merging relevant biomarkers for use in a prediction model.

resultsWe identified a distinct baseline inflammatory profile and changes in inflammatory networks among biomarkers in participants who subsequently developed mycobacterial or viral IRIS. We also developed a composite score incorporating biomarkers associated with IRIS (interleukin-6 [IL-6], IL-10, IL-27, sCD14, interferon-γ, tumor necrosis factor-α, hyaluronic acid, D-dimer, body mass index, and hemoglobin) that accurately predicted mycobacterial IRIS and death in this cohort.

conclusionsSystemic inflammatory profiles in PWH with severe immunosuppression are predictive of IRIS. Composite scores for the prediction of mycobacterial IRIS and death could be useful for risk stratification in PWH and lymphopenia initiating ART. CLINICAL TRIALS REGISTRATION: NCT00286767.

Indexed as

HIV InfectionsImmune Reconstitution Inflammatory SyndromeLymphopeniaBiomarkersHumansProspective StudiesBiomarkersbiomarkersHIVimmune reconstitution inflammatory syndrome (IRIS)tuberculosis

Identifiers

PMID32761193
PMCPMC8030712
OpenAlexW3151860576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.